L7|LIVE SF – Tuesday, June 13th, 2023
Digital Transformation
for Life Science Leaders
The L7|LIVE SF seminar will explore the ways in which digital technologies, such as unified platforms, are revolutionizing the biotech and life science industries, transforming business models, breaking down data silos, reducing turnaround times, and creating more consistent and reproducible processes. Our panel of experts will share their insights and experiences on these needed cutting-edge technologies and the trends laying the foundation for the future of life sciences.
This is a great opportunity to learn about the latest developments in the field, network with industry professionals, and gain a deeper understanding of how digital transformation is shaping the future of biotech.
join us in person
Tuesday, June 13th
- Lunch (noon – 1 pm PT)
- Seminar (1 pm – 5 pm PT)
- Reception (5 pm – 7 pm PT)
The St. Regis San Francisco
125 3rd St, San Francisco, CA 94103
join us virtually
Tuesday, June 13th
- Seminar (1 pm – 5 pm PT)
We understand that not everyone can join us in person for L7|LIVE SF, but we’ve got you covered! We are thrilled to offer this event as a hybrid experience, allowing you to participate from your office or the comfort of your home. Rest assured that you will have access to the same great content, valuable insights from industry experts, and thought-provoking discussions. We can’t wait for you to be part of this transformative event!
agenda
Steven Barash, Vice President, Strategy & Development + Brent Wilson, Solutions Consultant at L7 Informatics
On the IT side, outsourcing has traditionally been limited to basic support roles with scientific tasks remaining in-house. As software and data management tasks continue to evolve, maintaining the mix of development, administration, and analytical roles is proving challenging. The pool of available informatics resources is limited and, just like lab services, not all skills are needed all the time.
In this talk, we explore a new model for informatics in which the entire informatics role is handled as a service. “Informatics as a Service” provides companies with access to a range of skills at a fraction of the cost of in-sourcing, allowing companies to focus on their core mission while leveraging expert resources to handle their informatics and analysis needs.
Brent Wilson + Katherine Temple, Solutions Consultants at L7 Informatics
Steven Barash, Vice President, Strategy & Development + Brent Wilson, Solutions Consultant at L7 Informatics
By automating and standardizing laboratory processes, digitalization can improve the reproducibility and reliability of cell and gene therapies, leading to more consistent treatment outcomes for patients. Digitalization can also enhance the efficiency of laboratory workflows, reducing the time and cost required to develop and manufacture these therapies. This efficiency can help to accelerate the development of new treatments and improve patient access to these therapies.
Furthermore, digitalization can enable the integration of data from different stages of the cell and gene therapy development process, allowing researchers and clinicians to better understand the factors that influence treatment outcomes. This integrated approach can lead to the identification of new biomarkers, the development of personalized treatment regimens, and the optimization of manufacturing processes.
This digitalization offers transformative benefits, but also presents significant challenges.
One of the key challenges involved in developing and manufacturing these therapies is the complexity of the laboratory workflows due to the need to handle biological materials that are often fragile and require precise control of environmental conditions. Digitalization of these workflows requires the integration of multiple technologies, including robotics, data management systems, and artificial intelligence, to enable the automation and standardization of laboratory processes. Achieving this level of integration and standardization requires significant investment in infrastructure, personnel, and training.
Brent Wilson + Katherine Temple, Solutions Consultants at L7 Informatics
We also introduce TagGPT, an application layer within the data mesh, that uses foundational models (GPT3.5, BLOOM, LLaMA) along with data products (such as various phases of clinical trials) to build, refine and deploy fine-tune domain-centric (private) models and apps with built-in governance.
Join us for a talk on Tag.bio and learn how major pharma, non-profit organizations, and health systems are using this technology to find cures for devastating diseases, precision medicine, commercial insights/decisions, clinical trials, drug discovery, and promote collaboration (without explicitly moving data around). We show how the platform can combine clinical and genomics data products (with millions of variants and thousands of clinical parameters) using smart APIs and also connect clinical trials to RWE/RWD, adverse effects (FAERS), health economics, and outcomes.
In today’s complex life sciences landscape, gaining a competitive advantage and making informed decisions are paramount for success. This presentation explores the power of L7|Intelligence. Discover the key components of a robust L7|Intelligence strategy built around ESP, including data collection and integration, data warehousing and management, analytics and reporting, and more.
Learn from real-life examples of successful L7|Intelligence implementation in the industry and understand the benefits of L7|Intelligence, such as informed decision-making, competitive advantage, and operational efficiency. Walk away with best practices for implementing a successful L7|Intelligence strategy and unlock new levels of growth and innovation for your organization.
Richard Love, Director of Business Intelligence at L7 Informatics